 |
|
| Lessons from Tarceva in pancreatic cancer: where are we now
**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.** |
|
|
 | Lessons from Tarceva in pancreatic cancer: where are we now |  |
|
RSS FEED
| Joined: 05 Apr 2006 |
| Posts: 19275 |
|
|
|
 Posted: Tue Jun 10, 2008 10:26 am |
|
 |
 |
|
|
[img]http://www.co-oncology.com/pt/ServeCoverImage.gif?an=00001622-200807000-00000[/img]
Page: 454 DOI: 10.1097/CCO.0b013e32830218d6 Authors: Laurent-Puig, Pierre a,b,c; Taieb, Julien a,c
Read more...
Source: Current Opinion in Oncology - Current Table Of Contents
Current Opinion in Oncology - July 2008, Volume 20, Issue 4
|
|
|
|
|
All times are GMT - 7 Hours
Page 1 of 1
|
|
|
|
Forum Map
Site Map
| |
